|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/445 | (2006.01) |
| A61P 3/00 | (2006.01) |
| (11) | Number of the document | 4114390 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21715035.8 |
| Date of filing the European patent application | 2021-03-05 | |
| (97) | Date of publication of the European application | 2023-01-11 |
| (45) | Date of publication and mention of the grant of the patent | 2024-12-04 |
| (46) | Date of publication of the claims translation | 2025-02-10 |
| (86) | Number | PCT/US2021/020984 |
| Date | 2021-03-05 |
| (87) | Number | WO 2021/178737 |
| Date | 2021-09-10 |
| (30) | Number | Date | Country code |
| 202062986297 P | 2020-03-06 | US |
| (72) |
BENJAMIN, Elfrida , US
WU, Xiaoyang , US
|
| (73) |
Amicus Therapeutics, Inc. ,
3675 Market Street, Philadelphia, PA 19104,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Pacientų, turinčių GLA geno mutaciją, Fabri ligos gydymo būdai |
| METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING A MUTATION IN THE GLA GENE |
| Payment date | Validity (years) | Amount | |
| 2026-01-21 | 6 | 139.00 EUR |
| 2027-03-05 |